Sign inJoin waitlistJoin the waitlist

Kevin Lillehei

Chair of Neurosurgery · University of Colorado School of Medicine

Credentials: · · ·

History

Neurosurgery Department · University of Colorado School of Medicine
Present
University of Colorado School of Medicine
Present
University of Colorado School of Medicine
Present

University of South Florida
1992–1993
University of Colorado School of Medicine
1991–1992
University of Cincinnati
1990–1991
University of California-San Francisco
1989–1990
Massachusetts General Hospital Dana-Farber Cancer Institute Children's Hospital Boston
1988–1989
Cornell University Medical College
1987–1988
Drexel University College of Medicine/Hahnemann University
1986–1987
Barrow Neurological Institute
1985–1986
University of Michigan Health
1979–1985
University of Minnesota Medical School
1975–1979
Cornell University
1971–1975

Research

Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project
Journal of neurosurgery · 2003 · 516 citations
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
Journal of Translational Medicine · 2018 · 425 citations
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3…
JAMA Oncology · 2023 · 399 citations

Bette Kleinschmidt-DeMasters
77 papers
Denise Damek
21 papers
Ryan Ormond
18 papers · 10 as a resident
Margaret Wierman
15 papers
Samy Youssef
14 papers
JK
Janice Kerr
10 papers
LG
Laurie Gaspar
10 papers
Brian Kavanagh
9 papers
Katja Kiseljak-Vassiliades
9 papers
CC
Changhu Chen
8 papers
Douglas Ney
8 papers
AW
Allen Waziri
6 papers

Grants

General Clinical Research Center
National Center for Research Resources · M01
Project lead · $90.1K · University of Colorado Denver
1997–1999
Biomedical Research Support
National Center for Research Resources · S07
Project lead · University of Colorado Denver

Clinical trials

Cytotoxic T Cells and Interleukin-2 in Treating Adult Patients With Recurrent Brain Tumors
Study chair · Completed · Phase 1
University of Colorado, Denver
1994–1999
Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221
Site PI · Available
Northwest Biotherapeutics